These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 28165806)
1. Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies. Yi T; Tang D; Wang F; Zhang J; Zhang J; Wang J; Xu X; Zhang J Drug Deliv; 2017 Nov; 24(1):422-429. PubMed ID: 28165806 [TBL] [Abstract][Full Text] [Related]
2. [Borneol promotes oral absorption and penetration into brain of puerarin and catalpol]. Tang DD; Zhang J; Wang JR; Zhang JF; Xu XY Zhongguo Zhong Yao Za Zhi; 2016 Jul; 41(14):2720-2726. PubMed ID: 28905612 [TBL] [Abstract][Full Text] [Related]
3. Borneol and Α-asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors. Wu JY; Li YJ; Yang L; Hu YY; Hu XB; Tang TT; Wang JM; Liu XY; Xiang DX Drug Deliv; 2018 Nov; 25(1):1858-1864. PubMed ID: 30338713 [TBL] [Abstract][Full Text] [Related]
4. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery. Zhang Y; Wang R; Wu J; Shen Q Int J Pharm; 2012 May; 427(2):337-44. PubMed ID: 22366381 [TBL] [Abstract][Full Text] [Related]
5. Preparation and In Vitro/In Vivo Evaluation of Puerarin Solid Self-Microemulsifying Drug Delivery System by Spherical Crystallization Technique. Cheng G; Hu R; Ye L; Wang B; Gui Y; Gao S; Li X; Tang J AAPS PharmSciTech; 2016 Dec; 17(6):1336-1346. PubMed ID: 26694058 [TBL] [Abstract][Full Text] [Related]
6. Enhanced intestinal absorption of daidzein by borneol/menthol eutectic mixture and microemulsion. Shen Q; Li X; Li W; Zhao X AAPS PharmSciTech; 2011 Dec; 12(4):1044-9. PubMed ID: 21842308 [TBL] [Abstract][Full Text] [Related]
7. [Effects of different preparation technologies on concentrations of puerarin and catalpol in plasma and brain of rats after oral administration]. Tang DD; Zhang J; Wang JR; Zhang JF; Xu XY Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(5):940-947. PubMed ID: 28875652 [TBL] [Abstract][Full Text] [Related]
8. Oral Delivery of Puerarin Nanocrystals To Improve Brain Accumulation and Anti-Parkinsonian Efficacy. Xiong S; Liu W; Li D; Chen X; Liu F; Yuan D; Pan H; Wang Q; Fang S; Chen T Mol Pharm; 2019 Apr; 16(4):1444-1455. PubMed ID: 30811206 [TBL] [Abstract][Full Text] [Related]
9. Pep-1&borneol-Bifunctionalized Carmustine-Loaded Micelles Enhance Anti-Glioma Efficacy Through Tumor-Targeting and BBB-Penetrating. Guo X; Wu G; Wang H; Chen L J Pharm Sci; 2019 May; 108(5):1726-1735. PubMed ID: 30537472 [TBL] [Abstract][Full Text] [Related]
10. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat. Tu L; Yi Y; Wu W; Hu F; Hu K; Feng J Int J Pharm; 2013 Dec; 458(1):135-40. PubMed ID: 24120729 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565 [TBL] [Abstract][Full Text] [Related]
12. Characterization and evaluation of a self-microemulsifying drug delivery system containing tectorigenin, an isoflavone with low aqueous solubility and poor permeability. Zhang Y; He L; Yue S; Huang Q; Zhang Y; Yang J Drug Deliv; 2017 Nov; 24(1):632-640. PubMed ID: 28283000 [TBL] [Abstract][Full Text] [Related]
13. Effect of different doses of borneol on the pharmacokinetics of vinpocetine in rat plasma and brain after intraocular administration. Ma Q; Dai M; Zhang H; Bai L; He N Xenobiotica; 2020 May; 50(5):580-587. PubMed ID: 31424307 [TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability of puerarin using microemulsion vehicle. Wu H; Lu C; Zhou A; Min Z; Zhang Y Drug Dev Ind Pharm; 2009 Feb; 35(2):138-44. PubMed ID: 19040180 [TBL] [Abstract][Full Text] [Related]
15. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats. Zhou A; Lu T; Wang L; Lu C; Wang L; Wan M; Wu H Pharm Dev Technol; 2014 Sep; 19(6):743-7. PubMed ID: 23978005 [TBL] [Abstract][Full Text] [Related]
16. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin. Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809 [TBL] [Abstract][Full Text] [Related]
17. The use of borneol as an enhancer for targeting aprotinin-conjugated PEG-PLGA nanoparticles to the brain. Zhang L; Han L; Qin J; Lu W; Wang J Pharm Res; 2013 Oct; 30(10):2560-72. PubMed ID: 23615859 [TBL] [Abstract][Full Text] [Related]
18. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro. Wu CJ; Huang QW; Qi HY; Guo P; Hou SX Pharmazie; 2006 Sep; 61(9):783-8. PubMed ID: 17020156 [TBL] [Abstract][Full Text] [Related]
19. Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability. Zhang QL; Fu BM; Zhang ZJ Drug Deliv; 2017 Nov; 24(1):1037-1044. PubMed ID: 28687052 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interaction between puerarin and edaravone, and effect of borneol on the brain distribution kinetics of puerarin in rats. Gao C; Li X; Li Y; Wang L; Xue M J Pharm Pharmacol; 2010 Mar; 62(3):360-7. PubMed ID: 20487220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]